Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET | Source: Enovix Corporation Warrants Expired and…
StudyIn Announces Completion of its Transaction with SUN Education
LONDON, Sept. 3, 2025 /PRNewswire/ -- StudyIn, the world's most trusted higher…
GENESIS MAGMA RACING PREPARES FOR TESTING AFTER COMPLETION OF FIRST GMR001 HYPERCAR CHASSIS
Genesis Magma Racing is in the final stages of preparation for the…
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a…
Cango Inc. Announces Completion of Secondary Acquisition and Appointment of New Leadership Team
HONG KONG, July 23, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today…
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
AB Science announces the successful completion of a EUR 1.925 million private placement
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925…
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call
Core Adjusted EBITDA exceeds guidance; Company re-affirms FY 2026 outlook as AI-Centric…
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET | Source: Belite Bio, Inc - 500…
